Utilization and Safety of Concurrent Use of Abemaciclib and Radiation Therapy Among Patients With HR+, HER2− Metastatic Breast Cancer in the Real-World Setting

Purpose: Real-world data on tolerability of concurrent radiation therapy (RT) and abemaciclib are limited. This study described real-world utilization and safety of concurrent RT and abemaciclib in patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (H...

Full description

Bibliographic Details

Main Authors:	Wambui Gathirua-Mwangi, PhD, MPH, Sangmi Kim, PhD, MS, Holly Martin, PhD, Tasneem Lokhandwala, PhD, Shen Zheng, PhD, Eileen Farrelly, MPH, Erich Brechtelsbauer, PharmD, Sarah Rybowski, MD, Kamran A. Ahmed, MD
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2026-04-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109425002799
Tags:	Add Tag No Tags, Be the first to tag this record!